SUVRETTA CAPITAL MANAGEMENT, LLC - 13 Aug 2025 SCHEDULE 13G/A Report for Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX)

Filing Manager
SUVRETTA CAPITAL MANAGEMENT, LLC
Reporting Manager
Suvretta Capital Management, LLC
Security
Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
CMPX
Shares outstanding
171,965,354 shares
Disclosed Ownership
14,101,159 shares
Ownership
8.2%
Form type
SCHEDULE 13G/A
Filing time
21 Aug 2025, 09:07:13 UTC
Date of event
13 Aug 2025
Previous filing
13 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 8.2% ownership in Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX) on 13 Aug 2025."

Quick Takeaways

  • SUVRETTA CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G/A for Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX).
  • Disclosed ownership: 8.2%.
  • Date of event: 13 Aug 2025.

What Changed

  • Previous schedule filing date: 13 Aug 2025.
  • Current filing was accepted on 21 Aug 2025, 09:07.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Suvretta Capital Management, LLC 8.2% 14,101,159 0 14,101,159 By: /s/ Andrew Nathanson Andrew Nathanson / Authorized Signatory
Averill Master Fund, Ltd. 7.1% 12,229,050 0 12,229,050 By: /s/ Andrew Nathanson Andrew Nathanson / Authorized Signatory
Aaron Cowen 8.2% 14,101,159 0 14,101,159 Aaron Cowen By: /s/ Aaron Cowen

Sponsored